Home > Healthcare > Biotechnology > Bioservices > Single-cell Omics Market
Single-cell Omics Market Size
- Report ID: GMI6528
- Published Date: Aug 2023
- Report Format: PDF
Single-cell Omics Market Size
Single-cell Omics Market size accounted for USD 2.4 billion in 2022 and is estimated to grow at 20.2% to reach USD 15.5 billion by 2032. The escalating R&D investments in single-cell analysis research and rising funding programs serve as a pivotal growth driver for the market.
For instance, in November 2022, the Texas A&M University System has received a USD 1.19 million grant from the National Institutes of Health (NIH) to leverage single-cell sequencing technology. This surge in investment is propelled by the profound potential of single-cell omics technologies to revolutionize drug discovery, development, and personalized medicine. Such increasing investment in single-cell analysis research is anticipated to boost the market progress.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Single-cell Omics Market Size in 2022: | USD 2.4 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 20.2% |
| 2032 Value Projection: | USD 15.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 150 |
| Tables, Charts & Figures: | 208 |
| Segments covered: | Product Type, Application, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
The market refers to the segment of the biotechnology and life sciences industry that encompasses the development, production, and commercialization of technologies, tools, products, and services designed to study the molecular characteristics of individual cells at various omics levels.
Frequently Asked Questions (FAQ) :
Single-cell Omics Market Scope
